Home Cart Sign in  
Chemical Structure| 1051375-16-6 Chemical Structure| 1051375-16-6

Structure of Dolutegravir
CAS No.: 1051375-16-6

Chemical Structure| 1051375-16-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Dolutegravir (S/GSK1349572) is a highly potent and orally bioavailable HIV integrase strand transfer inhibitor with an IC50 of 2.7 nM for HIV-1 integrase-catalyzed strand transfer. Dolutegravir (S/GSK1349572) inhibits HIV-1 viral replication with an IC50 of 0.51 nM in peripheral blood mononuclear cells and maintains high potency against the HIV-1 Y143R, N155H, and G140S/Q148H mutants (EC50 = 3.6-5.8 nM).

Synonyms: S/GSK1349572; GSK1349572

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Dolutegravir

CAS No. :1051375-16-6
Formula : C20H19F2N3O5
M.W : 419.38
SMILES Code : O=C(C1=CN(C2=C(O)C1=O)C[C@]3([H])OCC[C@@H](C)N3C2=O)NCC4=CC=C(F)C=C4F
Synonyms :
S/GSK1349572; GSK1349572
MDL No. :MFCD20488027
InChI Key :RHWKPHLQXYSBKR-BMIGLBTASA-N
Pubchem ID :54726191

Safety of Dolutegravir

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Description
Dolutegravir is a highly potent and orally bioavailable inhibitor of HIV integrase strand transfer, with an IC50 of 2.7 nM for HIV-1 integrase-catalyzed strand transfer. It effectively inhibits HIV-1 viral replication with an IC50 of 0.51 nM in peripheral blood mononuclear cells. Dolutegravir also maintains significant potency against HIV-1 mutants Y143R, N155H, and G140S/Q148H (EC50=3.6-5.8 nM)[1][2].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00867152 Healthy Volunteer Phase 1 Completed - United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less <<
NCT00858455 Healthy Volunteer Phase 1 Completed - United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less <<
NCT01302847 HIV Infections Phase 1 Phase 2 Recruiting June 30, 2023 -
NCT01231542 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21287-5554 Less <<
NCT02178592 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 3 Active, not recruiting December 31, 2019 -
NCT02831673 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 3 Active, not recruiting March 3, 2020 -
NCT00708110 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 2 Completed - United States, California ... More >> GSK Investigational Site Bakersfield, California, United States, 93301 GSK Investigational Site Long Beach, California, United States, 90813 GSK Investigational Site Newport Beach, California, United States, 92663 GSK Investigational Site Northridge, California, United States, 91325 GSK Investigational Site San Francisco, California, United States, 94115 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80220 United States, District of Columbia GSK Investigational Site Washington, District of Columbia, United States, 20009 United States, Florida GSK Investigational Site Fort Lauderdale, Florida, United States, 33316 GSK Investigational Site Ft. Lauderdale, Florida, United States, 33306 GSK Investigational Site Orlando, Florida, United States, 32803 GSK Investigational Site Vero Beach, Florida, United States, 32960 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30308 United States, New Jersey GSK Investigational Site Hillsborough, New Jersey, United States, 08844 GSK Investigational Site Voorhees, New Jersey, United States, 08043 United States, New Mexico GSK Investigational Site Santa Fe, New Mexico, United States, 87505 United States, North Carolina GSK Investigational Site Charlotte, North Carolina, United States, 28209 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75204 GSK Investigational Site Dallas, Texas, United States, 75246 Less <<
NCT00708110 - Completed - -
NCT03327740 - Active, not recruiting June 30, 2019 -
NCT00828763 Healthy Volunteer Phase 1 Completed - United States, Wisconsin ... More >> GSK Investigational Site Madison, Wisconsin, United States, 53704 Less <<
NCT00996021 Healthy Subjects Phase 1 Completed - United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Less <<
NCT00883935 Healthy Volunteer Phase 1 Completed - United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less <<
NCT00774735 Healthy Subjects ... More >> Infection, Human Immunodeficiency Virus Less << Phase 1 Completed - United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less <<
NCT03095638 HIV Infections Phase 1 Completed - United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less <<
NCT00555035 Healthy Subjects PHASE1 COMPLETED 2025-02-08 GSK Investigational Site, Evan... More >>sville, Indiana, 47714, United States Less <<
NCT02486133 HIV-Infection Phase 3 Active, not recruiting December 2018 Germany ... More >> Klinikum rechts der Isar Munich, Germany, 81675 Less <<
NCT02878642 - Recruiting - France ... More >> Caen University Hospital Recruiting Caen, France, 14000 Contact: Jean Jacques PARIENTI, MD, PhD       parienti-jj@chu-caen.fr Less <<
NCT01622790 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT01332565 Infection, Human Immunodeficie... More >>ncy Virus Less << PHASE1 COMPLETED 2025-06-11 GSK Investigational Site, Cypr... More >>ess, California, 90630, United States Less <<
NCT00726336 Healthy Subjects Phase 1 Completed - United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less <<
NCT02987530 HIV-1 Infection Phase 3 Active, not recruiting December 2019 France ... More >> All The Regions Of The Country (40 Centers), France Less <<
NCT03360682 HIV-1-infection ... More >> Solid Organ Transplant Less << Phase 4 Recruiting January 2020 Spain ... More >> Hospital Clínico y provincial de Barcelona Recruiting Barcelona, Spain, 08036 Contact: Anna Cruceta Arboles, MD    +34 93 2275400 ext 4380    acruceta@clinic.ub.es Less <<
NCT01449929 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 3 Completed - -
NCT01231529 Healthy Subjects|Hepatic Impai... More >>rment|Infection, Human Immunodeficiency Virus|HIV Infections Less << PHASE1 COMPLETED 2011-06-04 GSK Investigational Site, Minn... More >>eapolis, Minnesota, 55404, United States Less <<
NCT01449929 - Completed - -
NCT01536873 Infection, Human Immunodeficie... More >>ncy Virus|HIV Infections Less << COMPLETED 2016-09-23 GSK Investigational Site, Phoe... More >>nix, Arizona, 85012, United States|GSK Investigational Site, San Francisco, California, 94115, United States|GSK Investigational Site, Denver, Colorado, 80218, United States|GSK Investigational Site, Fort Lauderdale, Florida, 33311, United States|GSK Investigational Site, Fort Lauderdale, Florida, 33316, United States|GSK Investigational Site, Orlando, Florida, 32803, United States|GSK Investigational Site, Saint Petersburg, Florida, 33701, United States|GSK Investigational Site, Vero Beach, Florida, 32960, United States|GSK Investigational Site, Atlanta, Georgia, 30322, United States|GSK Investigational Site, Chicago, Illinois, 60612, United States|GSK Investigational Site, Chicago, Illinois, 60613, United States|GSK Investigational Site, Chicago, Illinois, 60657, United States|GSK Investigational Site, Topeka, Kansas, 66606, United States|GSK Investigational Site, Saint Louis, Missouri, 63139, United States|GSK Investigational Site, Omaha, Nebraska, 68198, United States|GSK Investigational Site, Bronx, New York, 1057, United States|GSK Investigational Site, New York, New York, 10011, United States|GSK Investigational Site, Chapel Hill, North Carolina, 27599-7215, United States|GSK Investigational Site, Lancaster, Pennsylvania, 17604, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19107, United States|GSK Investigational Site, Austin, Texas, 78705, United States|GSK Investigational Site, Dallas, Texas, 75204, United States|GSK Investigational Site, Houston, Texas, 77004, United States|GSK Investigational Site, Houston, Texas, 77098, United States|GSK Investigational Site, Graz, A-8020, Austria|GSK Investigational Site, Linz, A-4020, Austria|GSK Investigational Site, Vienna, A-1140, Austria|GSK Investigational Site, Antwerpen, 2000, Belgium|GSK Investigational Site, Brussels, 1000, Belgium|GSK Investigational Site, Liege, 4000, Belgium|GSK Investigational Site, Ipanema, Rio De Janeiro, 22410-906, Brazil|GSK Investigational Site, Macae, Rio De Janeiro, 27910-210, Brazil|GSK Investigational Site, Porto Alegre, Rio Grande Do Sul, 2006, Brazil|GSK Investigational Site, Sao Paulo, S?o Paulo, 04121-000, Brazil|GSK Investigational Site, Fortaleza, 60455-610, Brazil|GSK Investigational Site, Maceió, 57035-110, Brazil|GSK Investigational Site, Ribeir?o Preto, 14048-900, Brazil|GSK Investigational Site, Rio de Janeiro, 20520-054, Brazil|GSK Investigational Site, Rio de Janeiro, 20725-090, Brazil|GSK Investigational Site, Rio de Janeiro, 21040-900, Brazil|GSK Investigational Site, Sao Paulo, 01246-000, Brazil|GSK Investigational Site, Vittoria, 29020-020, Brazil|GSK Investigational Site, Vancouver, British Columbia, V6Z 1Y6, Canada|GSK Investigational Site, Hamilton, Ontario, L8N3Z5, Canada|GSK Investigational Site, Toronto, Ontario, M5G 1K2, Canada|GSK Investigational Site, Montreal, Quebec, H2L 4P9, Canada|GSK Investigational Site, Bordeaux cedex, 33076, France|GSK Investigational Site, Le Kremlin-Bicêtre Cedex, 94275, France|GSK Investigational Site, Marseille, 13274, France|GSK Investigational Site, Nice, 06202, France|GSK Investigational Site, Paris Cedex 10, 75475, France|GSK Investigational Site, Paris Cedex 14, 75679, France|GSK Investigational Site, Paris Cedex 18, 75877, France|GSK Investigational Site, Paris Cedex 20, 75970, France|GSK Investigational Site, Paris, 75012, France|GSK Investigational Site, Paris, 75013, France|GSK Investigational Site, Paris, 75015, France|GSK Investigational Site, Freiburg, Baden-Wuerttemberg, 79106, Germany|GSK Investigational Site, Stuttgart, Baden-Wuerttemberg, 70197, Germany|GSK Investigational Site, Frankfurt, Hessen, 60596, Germany|GSK Investigational Site, Osnabrueck, Niedersachsen, 49090, Germany|GSK Investigational Site, Bonn, Nordrhein-Westfalen, 53127, Germany|GSK Investigational Site, Koeln, Nordrhein-Westfalen, 50674, Germany|GSK Investigational Site, Luebeck, Schleswig-Holstein, 23538, Germany|GSK Investigational Site, Mannheim, 68161, Germany|GSK Investigational Site, Genova, Liguria, 16128, Italy|GSK Investigational Site, Genova, Liguria, 16132, Italy|GSK Investigational Site, Milano, Lombardia, 20127, Italy|GSK Investigational Site, Pavia, Lombardia, 27100, Italy|GSK Investigational Site, Bagno A Ripoli (FI), Toscana, 50011, Italy|GSK Investigational Site, Firenze, Toscana, 50134, Italy|GSK Investigational Site, Modena, 41124, Italy|GSK Investigational Site, Venezia, 30122, Italy|GSK Investigational Site, Szczecin, 71-455, Poland Less <<
NCT03760458 HIV Infections Phase 1 Phase 2 Not yet recruiting August 2023 United States, Illinois ... More >> Lurie Children's Hospital of Chicago (LCH) CRS Not yet recruiting Chicago, Illinois, United States, 60614-3393 Contact: Margaret Ann Sanders, M.P.H.    312-227-8275    msanders@luriechildrens.org Less <<
NCT01209065 Infections, Human Immunodefici... More >>ency Virus and Herpesviridae Less << Phase 1 Completed - United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less <<
NCT03078556 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT02893488 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT03198884 - Active, not recruiting May 1, 2018 -
NCT03683524 HIV-1 Infection Phase 4 Not yet recruiting October 2020 -
NCT01098526 Infections, Human Immunodefici... More >>ency Virus and Herpesviridae Less << Phase 1 Completed - United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less <<
NCT01404806 Healthy Adult Females Phase 1 Completed - United States, North Carolina ... More >> University of North Carolina, Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less <<
NCT02370979 HIV-1 Infection Phase 4 Unknown July 2017 France ... More >> Centre hospitalier de Belfort-Montbéliard Active, not recruiting Belfort, France, 90000 Centre hospitalier de Colmar Recruiting Colmar, France, 68024 Contact: Martin MARTINOT, MD       martin.martinot@ch-colmar.fr    Centre hospitalier de Mulhouse Recruiting Mulhouse Cedex, France, 68070 Contact: Geneviève BECK WIRTH, MD       beck-wirthg@ch-mulhouse.fr    Hôpitaux Universitaire de Strasbourg Recruiting Strasbourg Cedex, France, 67091 Contact: David REY, PhD       david.rey@chru-strasbourg.fr Less <<
NCT02384395 HIV Acute HIV... More >> Infection Less << Not Applicable Recruiting July 2021 United States, North Carolina ... More >> University of North Carolina Recruiting Chapel Hill, North Carolina, United States, 27599 Duke University Health System Recruiting Durham, North Carolina, United States, 27710 Contact: Kara McGee, MSPH, PA-C    919-668-0242    kara.mcgee@duke.edu    Principal Investigator: Mehri McKellar, MD Less <<
NCT02513147 HIV-1 Phase 4 Completed - Spain ... More >> Hospital Universitari Vall d'Hebron Barcelona, Spain, 08035 Less <<
NCT02738931 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT00774111 Healthy Subjects PHASE1 COMPLETED 2025-12-08 GSK Investigational Site, Buff... More >>alo, New York, 14202, United States Less <<
NCT00631592 Healthy Subjects PHASE1 COMPLETED 2025-06-08 GSK Investigational Site, Madi... More >>son, Wisconsin, 53704, United States Less <<
NCT01366547 Healthy Subjects ... More >> Infection, Human Immunodeficiency Virus Less << Phase 1 Completed - United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less <<
NCT01762995 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - -
NCT02777229 HIV-1 Infection Phase 3 Active, not recruiting July 2018 Cameroon ... More >> Cité verte Hospital Yaoundé, Cameroon Hopital Central Yaoundé, Cameroon Military Hospital Yaoundé, Cameroon Less <<
NCT00950859 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 2 Completed - -
NCT02069834 HIV Infection ... More >> HAART-treated Virologically Controlled Less << Phase 2 Phase 3 Withdrawn(One of the both Fund... More >>er partners decided to stop the study before the initiation thus no product provided and no funding to realize the study) Less << October 2017 France ... More >> CHU Guadeloupe Point-a-pitre, Guadeloupe, France, 97159 CHU de Fort de France Fort de France, Martinique, France, 87261 Chu Jean Minjoz Besançon, France, 25030 Hôpital Avicenne Bobigny, France, 93000 Hôpital Jean Verdier Bondy, France, 93140 CHU de Bordeaux Bordeaux, France, 33076 CHU de DIJON Dijon, France, 21079 CHD La Roche sur Yon La Roche sur Yon, France, 85925 CHU Kremlin Bicêtre Le Kremlin Bicetre, France, 94275 Hôpital Perpetuel Secours Levallois-perret, France, 92300 CHU de Nantes Nantes, France, 44093 Hôpital Saint Louis Paris Cedex 10, France, 75475 CHU BICHAT - Claude Bernard Paris cedex 18, France, 75877 CHU Hôtel Dieu Paris Paris, France, 75004 Hôpital La Pitié Salpêtrière Paris, France, 75013 Hôpital Necker - enfants Malades Paris, France, 75015 Hôpital Européen Georges Pompidou Paris, France, 75908 CHU de Rennes - Hôpital Pontchaillou Rennes, France, 35000 CH Delafontaine Saint Denis, France, 93200 CHU Saint Etienne Saint Etienne, France, 42055 CHU de Strasbourg Strasbourg, France, 67091 Hôpital FOCH Suresnes, France, 92150 CHU Toulouse Toulouse, France, 31059 CHRU de Tours Tours Cedex 09, France, 37044 CHU de Nancy VANDOEUVRE LES NANCY cedex, France, 54511 Less <<
NCT02064374 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT02656511 HIV Phase 4 Recruiting April 2020 United States, California ... More >> San Francisco General Hospital Recruiting San Francisco, California, United States, 94110 Contact: Sulggi A Lee, MD PhD       Sulggi.Lee@ucsf.edu    Contact: Steven G Deeks, MD       Steven.Deeks@ucsf.edu Less <<
NCT02337322 Acquired Immune Deficiency Syn... More >>drome Virus Less << Phase 4 Active, not recruiting December 2019 Spain ... More >> Hospital Clinic of Barcelona Barcelona, BCN, Spain, 08013 Less <<
NCT00950859 - Completed - -
NCT02582684 HIV-1 Infection Phase 2 Completed - -
NCT01098513 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less <<
NCT02715479 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less <<
NCT01827540 HIV-infection/AIDS Phase 1 Completed - United States, Florida ... More >> SeaView Research, Inc. Miami, Florida, United States, 33126 Less <<
NCT02582684 - Completed - -
NCT01382238 Infections, Human Immunodefici... More >>ency Virus and Herpesviridae Less << Phase 1 Completed - United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less <<
NCT02659761 Human Immunodeficiency Virus Phase 4 Recruiting March 2019 Ireland ... More >> Mater Misericordiae University Hospital Recruiting Dublin, Ireland, 7 Contact: Willard Tinago, PhD       wtinago@gmail.com    Contact: Patrick WG Mallon, MB BCh, PhD, FRCPI       paddy.mallon@ucd.ie    Principal Investigator: Patrick Mallon, MB BCh, PhD, FRCPI          Sub-Investigator: Gerard Sheehan, MB BCh BAO, FRCPI          Sub-Investigator: John Lambert, MD, PhD Less <<
NCT03017872 HIV Infections Phase 4 Recruiting December 28, 2021 Argentina ... More >> Hospital G de Agudos JM Ramos Mejia Not yet recruiting Buenos Aires, Ciudad De Buenos Aires, Argentina, C1221ADC Contact: Marcelo Losso    5411 4127 0276    mlosso@hivramos.org.ar    Contact: Guillermo Viloria    5411 4931 5252    gviloria@hivramos.org.ar    Principal Investigator: Marcelo Losso, M.D.          Hospital Dr Diego Paroissien Not yet recruiting Isidro Casanova, Provincia De Buenos Aires, Argentina, 1765 Contact: Eduardo Warley    5411 1541 897 181    eduwarley@yahoo.com.ar    Contact: Maria Ines Vieni    5411 1136 877 377 ext 3340    inesvieni@gmail.com    Principal Investigator: Eduardo Warley, M.D.          CAICI Not yet recruiting Rosario, Provincia De Santa Fe, Argentina, S2000PBJ Contact: Sergio Lupo    54 9 341 515 7704    drsergiolupo@gmail.com    Contact: Luciana Peroni    54 341 424 8045    administracioncaici@gmail.com    Principal Investigator: Sergio Lupo, M.D.          Hospital Interzonal de Agudos San Juan de Dios Recruiting La Plata, Argentina, 1900 Contact: Martha Michaan    +54 9221 5765 131    mgmichaan@yahoo.com.ar    Principal Investigator: Martha Michaan, M.D.          Brazil Laboratório de Pesquisa Clinica Em Hiv/Aids - Instituto Nacional de Infectologia - Fiocruz Not yet recruiting Rio de Janeiro, Brazil, 21040-360 Contact: Beatriz Grinsztejn    +552122707064    beatriz.grinsztejn@gmail.com    Contact: Kelly Gama    +552138659614    kelly.gama@ini.fiocruz.br    Principal Investigator: Beatriz Grinsztejn, MD, PhD          Chile Hospital San Borja-Arriaran Not yet recruiting Santiago, Chile, 8360159 Contact: Marcelo Wolff    562- 555 6206    marcewolff@yahoo.com    Contact: Gladys Allendes    562-555-6206    gladys_allendes@yahoo.es    Principal Investigator: Marcelo Wolff, MD          Colombia ASISTENCIA Cientifica De Alta Complejidad S.A.S. Not yet recruiting Bogota, Colombia, 110010 Contact: Otto Sussmann    57-1- 5107600 ext 104    osussmann@gmail.com    Contact: Ana Julia Rojas    57-1-5107600 ext 128    coord.investigaciones@asistenciacientifica.com    Principal Investigator: Otto Sussmann, M.D.          Guinea Centre de traitementambulatoire de Donka ( Hopital de jour) Not yet recruiting Conakry, Guinea, BP:5845 Contact: Mohamed Cisse    +224 622 292 590    cissebibi1@gmail.com    Contact: Thierno Mamadou Tounkara    +224 622 318 171    tounkm@yahoo.fr    Principal Investigator: Mohamed Cisse, Prof.          India YRG Care Not yet recruiting Chennai, Tamil Nadu, India, 600113 Contact: Nagalingeswaran Kumarasamy    91 917 691 2007    kumarasamy@yrgcare.org    Contact: Faith Beulah    91 44 39106811    beulah@yrgcare.org    Principal Investigator: Nagalingeswaran Kumarasamy, MD          Malaysia University of Malaya Medical Centre Recruiting Kuala Lumpur, Malaysia, 59100 Contact: Raja Iskandar Shah Raja Azwa    603-79493834    iskandar.azwa@gmail.com    Contact: Margaret Tan    603-79492622    margarettan455@gmail.com    Principal Investigator: Raja Iskandar Shah Raja Azwa, MBChB, MRCP          Mali University of Sciences, Techniques and Technologies of Mali, University Clinical Research Center (UCRC) Not yet recruiting Bamako, Mali Contact: Sounkalo Doa    +223 72274971    sounkalod@icermali.org    Contact: Yacouba Cissoko    +22374567649 or +22397195994    ycissoko@hotmail.com    Principal Investigator: Sounkalo Doa, Prof.          Mexico Morales Vargas Centro de Investigacion SC Not yet recruiting León, Guanajuato, Mexico, 37000 Contact: Juan Luis Mosqueda Gomez    +52 (477) 1310037    luis_mosqueda@yahoo.com    Contact: Jorge Morales Vargas    +52 (477) 7160714    mnc.jorge@hotmail.com    Hospital Civil de Guadalajara Not yet recruiting Guadalajara, Jalisco, Mexico, 44280 Contact: Jaime Andrade-Villanueva       jandradev@msn.com    Contact: Angeles González-Hernández    5233 3614 7586    angelesghdez1@gmail.com    Principal Investigator: Jaime Andrade-Villanueva, M.D.          Instituto Nacional de Ciencias Medicas y Nutriciòn Salvador Zubiran Not yet recruiting Mexico City, Mexico, 14080 Contact: Juan Sierra Madero    52 5556559675    jsmadero@yahoo.com    Contact: Izchel Loyo       iz.inncm@outlook.com    Principal Investigator: Juan Sierra Madero, M.D.          Nigeria Institute of Human Virology, Nigeria (IHVN) Not yet recruiting Abuja, Nigeria, 9396 Contact: Ernest Ekong    +2348023107612    ernestekong@ihvnigeria.org    Contact: Nnakelu Eriobu    +2347039469273    neriobu@ihvnigeria.org    Principal Investigator: Ernest Ekong, MD          South Africa Desmond Tutu HIV Foundation Recruiting Cape Town, South Africa, 7925 Contact: Richard Kaplan       Richard.Kaplan@hiv-research.org.za    Contact: Christie Heiberg    27 21 406 3621    Christie.Heiberg@hiv-research.org.za    Principal Investigator: Richard Kaplan, M.D.          Clinical HIV Research Unit (CHRU), Wits Health Consotium (Pty) Ltd Recruiting Johannesburg, South Africa, 2041 Contact: Noluthando Mwelase       tmwelase@witshealth.co.za    Contact: Pauline Vunandala    27 11 276 8800    pvunandlala@witshealth.co.za    Principal Investigator: Noluthando Mwelase, MBCHB          Perinatal HIV Research Unit (PHRU), Chris Hani Baragwanath Hospital Recruiting Soweto, South Africa, 1864 Contact: Lerato Mohapi       mohapil@hivsa.com    Contact: Debra Peters    27 11 989 9700    petersd@phru.co.za    Principal Investigator: Lerato Mohapi, BSc, MBBCh          Thailand HIV-NAT (The HIV Netherlands Australia Thailand Research Collaboration), Thai Red Cross AIDS Research Centre Recruiting Bangkok, Thailand, 10330 Contact: Anchalee Avihingsanon    +662 652 3040 ext 107    anchaleea2009@gmail.com    Contact: Kanitta Pussadee    +662 652 3040 ext 202    kanitta.p@hivnat.org    Principal Investigator: Anchalee Avihingsanon, M.D.          Chiangrai Prachanukroh Hospital Not yet recruiting Chiang Rai, Thailand, 57000 Contact: Pacharee Kantipong    66818859195    pachareek@hotmail.com    Contact: Supawadee Pongprapass    66819616900    npudit@hotmail.com    Principal Investigator: Pacharee Kantipong, M.D.          Srinagarind Hospital, Khon Kaen University Recruiting Khon Kaen, Thailand, 40002 Contact: Ploenchan Chetchotisakd    6643363168    ploencha@kku.ac.th    Contact: Anchalee Tiyabut    6643363169    atiyabut@yahoo.com    Principal Investigator: Ploenchan Chetchotisakd, M.D.          Bamrasnaradura Infectious Diseases Institute Recruiting Nonthaburi, Thailand, 11000 Contact: Weerawat Manosuthi       drweerawat@hotmail.com    Contact: Supeda Thongyen    6625903631    supeda_t@yahoo.com    Principal Investigator: Weerawat Manosuthi, M.D.          Zimbabwe University of Zimbabwe Clinical Research Centre Recruiting Harare, Zimbabwe, +263 Contact: James G Hakim    263 772225489    Jhakim@mweb.co.zw    Contact: Shepherd Mudzingwa    263 4 701717    smudzingwa@yahoo.com    Principal Investigator: James G Hakim, M.D. Less <<
NCT01467518 Infections, Human Immunodefici... More >>ency Virus and Hepatitis Less << Phase 1 Completed - Canada, Ontario ... More >> GSK Investigational Site Toronto, Ontario, Canada, M5V 2T3 Less <<
NCT02219217 HIV Phase 1 Completed - United Kingdom ... More >> St Stephen's AIDS Trust London, United Kingdom, SW10 9NH Less <<
NCT02185300 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT02218320 - Completed - United States, North Carolina ... More >> Clinical and Translational Research Center, UNC Hospitals Chapel Hill, North Carolina, United States, 27599 Less <<
NCT02218320 - Completed - -
NCT02211690 Human Immunodeficiency Virus Phase 4 Completed - Australia, New South Wales ... More >> St Vincent's Hospital Centre for Applied Medical Research Darlinghurst, New South Wales, Australia, 2010 Sydney Sexual Health Centre Sydney, New South Wales, Australia, 2000 Clinic 16, Royal North Shore Hospital Sydney, New South Wales, Australia, 2065 Australia, Victoria Melbourne Sexual Health Centre Carlton, Victoria, Australia, 3053 Alfred Hospital Melbourne, Victoria, Australia, 3004 Less <<
NCT02542852 HIV-1 Infection Phase 2 Recruiting December 2017 Italy ... More >> Ospedale San Raffaele Scientific Institute Recruiting Milan, Italy, 20127 Less <<
NCT03336346 - Recruiting December 2018 Botswana ... More >> Botswana-UPenn Partnership Recruiting Gaborone, Botswana Contact: Chelsea Morroni, MD    26776524112    chelseaamorroni@gmail.com    Principal Investigator: Chelsea Morroni, MD Less <<
NCT02067767 HIV-1 Infection Phase 2 Completed - France ... More >> La Roche-sur-Yon Hospital La Roche-sur-Yon, France Nantes University Hospital Nantes, France Less <<
NCT02499978 HIV/AIDS Phase 2 Phase 3 Withdrawn - United States, California ... More >> Stanford Univerity Stanford, California, United States, 94305 United States, Colorado University of Colorado Aurora, Colorado, United States, 80045 Less <<
NCT01467531 Infections, Human Immunodefici... More >>ency Virus and Hepatitis Less << Phase 1 Completed - United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less <<
NCT02242799 Malaria HIV Phase 1 Completed - Uganda ... More >> Infectious Diseases Institute Kampala, Uganda Less <<
NCT03033836 HIV Infections Phase 4 Active, not recruiting July 2019 Argentina ... More >> Fundacion Huesped Ciudad de Buenos Aires, Buenos Aires, Argentina, C1202ABB Less <<
NCT01966822 HIV-1 Infection Phase 3 Completed - Spain ... More >> GermansTrias i Pujol Hospital Badalona, Barcelona, Spain, 08916 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Hospital Clínico San Carlos Madrid, Spain, 28040 Less <<
NCT03493568 HIV-1-infection Phase 3 Recruiting July 31, 2020 Italy ... More >> Ospedale San Raffaele Recruiting Milan, Lombardia, Italy, 20127 Contact: ADRIANO LAZZARIN    0226437939    lazzarin.adriano@hsr.it    Contact: Elisabetta Carini    0226437934    carini.elisabetta@hsr.it    Ospedale San Raffaele Scientific Institute Recruiting Milan, Italy, 20127 Less <<
NCT01425099 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less <<
NCT02596334 HIV Phase 3 Terminated(5 patients on tivic... More >>ay had virological failure) Less << - France ... More >> CHD de VENDEE La Roche sur Yon, France, 85925 CH de LA ROCHELLE La Rochelle, France, 17019 CHRU de NANTES Nantes, France, 44093 CH de NIORT Niort, France, 79021 CHR d'ORLEANS Orleans, France, 45032 CHRU de POITIERS Poitiers, France, 86021 CHU de STRASBOURG Strasbourg, France, 67000 CHRU de TOURS Tours, France, 37044 CHU de NANCY Vandoeuvre Les Nancy, France, 54511 Less <<
NCT01499199 Infection, Human Immunodeficie... More >>ncy Virus Less << PHASE3 COMPLETED 2025-05-14 GSK Investigational Site, Los ... More >>Angeles, California, 90069, United States|GSK Investigational Site, San Diego, California, 92103, United States|GSK Investigational Site, Providence, Rhode Island, 02906, United States Less <<
NCT01499199 Infection, Human Immunodeficie... More >>ncy Virus Less << PHASE3 COMPLETED 2025-05-14 GSK Investigational Site, Los ... More >>Angeles, California, 90069, United States|GSK Investigational Site, San Diego, California, 92103, United States|GSK Investigational Site, Providence, Rhode Island, 02906, United States Less <<
NCT01068925 Infection, Human Immunodeficie... More >>ncy Virus|HIV Infections Less << PHASE1 COMPLETED 2010-04-05 GSK Investigational Site, Aust... More >>in, Texas, 78744, United States Less <<
NCT02263326 HIV Infection Phase 3 Completed - United States, California ... More >> University of California San Diego San Diego, California, United States United States, Georgia Emory University Atlanta, Georgia, United States United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Massachusetts Brigham and Women's Hospital Boston, Massachusetts, United States United States, New York Cornell University New York, New York, United States United States, Ohio University of Cincinnati Cincinnati, Ohio, United States The Ohio State University Columbus, Ohio, United States Less <<
NCT03249181 HIV-1-infection ... More >> Pregnancy Related Less << Phase 3 Active, not recruiting March 2021 South Africa ... More >> University of Cape Town Cape Town, Western Cape, South Africa Uganda Infectious Diseases Institute Kampala, Uganda Less <<
NCT01459315 Healthy Phase 1 Completed - United States, North Carolina ... More >> University of North Carolina, Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less <<
NCT02527096 HIV-1 Infection Phase 2 Completed - France ... More >> Hôpital Avicenne Bobigny, France, 93009 Hôpital Saint-André Bordeaux, France, 33000 Hôpital Gabriel Montpied Clermont-Ferrand, France, 63003 Hôpital du Bocage Dijon, France, 21079 Hôpital Pierre Zobda-Quitman Fort de France, France, 97261 Hôpial Bicêtre Le Kremelin Bicêtre, France, 94270 Hôpital Gui de Chaudiac Montpellier, France, 34295 Hôpital de l'Hotel Dieu Nantes, France, 44093 Hôpital Saint-Louis Paris, France, 75010 Hôpital Saint-Antoine Paris, France, 75012 Hôpital Pitié-Salpêtrière Paris, France, 75013 Hôpital Necker Paris, France, 75015 Hôpital Bichat Paris, France, 75018 Centre hospitalier de Pernignan Perpignan, France, 66046 Hôpital Pontchaillou Rennes, France, 35033 Hôpital Purpan Toulouse, France, 31059 Hôpital Gustave Dron Tourcoing, France, 59208 Hôpital Bretonneau Tours, France, 37044 Less <<
NCT03602690 HIV/AIDS Phase 2 Recruiting October 3, 2020 Cambodia ... More >> NCHADS Recruiting Phnom Penh, Cambodia Contact: Sun Ly Penh, MD Less <<
NCT02263326 - Completed - -
NCT01353716 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Minnesota ... More >> GSK Investigational Site Minneapolis, Minnesota, United States, 55404 Less <<
NCT01328041 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 3 Completed - -
NCT02285374 HIV Phase 4 Unknown December 2015 United Kingdom ... More >> Chelsea and Westminster Hospital London, United Kingdom, SW10 9TH Less <<
NCT01498861 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Florida ... More >> GSK Investigational Site Miami, Florida, United States, 33169 Less <<
NCT01328041 - Completed - -
NCT03199690 HIV-1-infection ... More >> Tuberculosis Less << Phase 1 Not yet recruiting March 2018 -
NCT02551523 Monotherapy D... More >>olutegravir Primary HIV Infection Treatment Efficacy Less << Phase 2 Active, not recruiting February 2021 Switzerland ... More >> University Hospital Zurich, University of Zurich Zurich, Switzerland, 8091 Less <<
NCT02245022 HIV Pregnancy Phase 2 Phase 3 Active, not recruiting December 2018 South Africa ... More >> Desmond Tutu HIV Foundation Cape Town, Western Cape, South Africa Uganda Infectious Diseases Institute Kampala, Uganda Less <<
NCT02076386 Infection, Human Immunodeficie... More >>ncy Virus Less << COMPLETED 2017-07-05 GSK Investigational Site, Frei... More >>burg, Baden-Wuerttemberg, 79106, Germany|GSK Investigational Site, Mannheim, Baden-Wuerttemberg, 68161, Germany|GSK Investigational Site, Stuttgart, Baden-Wuerttemberg, 70197, Germany|GSK Investigational Site, Tuebingen, Baden-Wuerttemberg, 72076, Germany|GSK Investigational Site, Fuerth, Bayern, 90762, Germany|GSK Investigational Site, Muenchen, Bayern, 80331, Germany|GSK Investigational Site, Muenchen, Bayern, 80335, Germany|GSK Investigational Site, Muenchen, Bayern, 80336, Germany|GSK Investigational Site, Muenchen, Bayern, 80801, Germany|GSK Investigational Site, Muenchen, Bayern, 81675, Germany|GSK Investigational Site, Frankfurt am Main, Hessen, 60590, Germany|GSK Investigational Site, Frankfurt, Hessen, 60311, Germany|GSK Investigational Site, Hannover, Niedersachsen, 30159, Germany|GSK Investigational Site, Osnabrueck, Niedersachsen, 49090, Germany|GSK Investigational Site, Aachen, Nordrhein-Westfalen, 52062, Germany|GSK Investigational Site, Bochum, Nordrhein-Westfalen, 44787, Germany|GSK Investigational Site, Dortmund, Nordrhein-Westfalen, 44137, Germany|GSK Investigational Site, Duesseldorf, Nordrhein-Westfalen, 40237, Germany|GSK Investigational Site, Koeln, Nordrhein-Westfalen, 50674, Germany|GSK Investigational Site, Muenster, Nordrhein-Westfalen, 48143, Germany|GSK Investigational Site, Koblenz, Rheinland-Pfalz, 56073, Germany|GSK Investigational Site, Mainz, Rheinland-Pfalz, 55116, Germany|GSK Investigational Site, Magdeburg, Sachsen-Anhalt, 39120, Germany|GSK Investigational Site, Berlin, 10243, Germany|GSK Investigational Site, Berlin, 10405, Germany|GSK Investigational Site, Berlin, 10439, Germany|GSK Investigational Site, Berlin, 10707, Germany|GSK Investigational Site, Berlin, 10777, Germany|GSK Investigational Site, Berlin, 10961, Germany|GSK Investigational Site, Berlin, 13347, Germany|GSK Investigational Site, Berlin, 14057, Germany|GSK Investigational Site, Chemnitz, 09111, Germany|GSK Investigational Site, Hamburg, 20099, Germany|GSK Investigational Site, Hamburg, 20146, Germany|GSK Investigational Site, Hamburg, 20246, Germany|GSK Investigational Site, Koeln, 50668, Germany|GSK Investigational Site, Koeln, 50679, Germany|GSK Investigational Site, Weimar, 99427, Germany Less <<
NCT03224338 HIV II Infection Phase 2 Recruiting June 2019 Portugal ... More >> Centro Hospitalar de Lisboa Central Hospital Curry Cabral Recruiting Lisboa, Portugal Principal Investigator: Fernando Maltez, MD          Centro Hospitalar de Lisboa Ocidental Hospital de Egas Moniz Recruiting Lisboa, Portugal Principal Investigator: Kamal Mansinho, MD          Centro Hospitalar Lisboa Norte Hospital de Santa Maria Recruiting Lisboa, Portugal Principal Investigator: Nuno Janeiro, MD          Hospital Beatriz Ângelo Loures Recruiting Lisboa, Portugal Principal Investigator: Paulo Rodrigues, MD          Hospital Garcia de Orta Recruiting Lisboa, Portugal Principal Investigator: Nuno Marques, MD          Hospital Professor Doutor Fernando Fonseca Amadora Recruiting Lisboa, Portugal Principal Investigator: Patricia Pacheco, MD Less <<
NCT03094507 HIV Phase 1 Completed - United Kingdom ... More >> St Stephen's Centre London, United Kingdom, SW10 9NH Less <<
NCT02211482 HIV-1 Infection Phase 4 Completed - Argentina ... More >> Fundacion Huesped Caba, Buenos Aires, Argentina, C1202ABB Less <<
NCT02404805 HIV Hepatitis... More >> C Less << Not Applicable Completed - United States, Colorado ... More >> University of Colorado Anschutz Medical Campus Aurora, Colorado, United States, 80045 Less <<
NCT02976259 HIV Infection Primary PHASE3 COMPLETED 2025-12-18 -
NCT01568892 HIV Infections Phase 3 Completed - -
NCT02572947 Human Immunodeficiency Virus|D... More >>olutegravir|Monotherapy|Treatment Efficacy Less << PHASE2 COMPLETED 2025-09-17 University Hospitals of Geneva... More >>, HIV unit, Geneva, 1205, Switzerland Less <<
NCT01568892 - Completed - -
NCT02098837 HIV PHASE4 COMPLETED 2017-12-04 Insititute Of Tropical Medicin... More >>e Antwerp, Antwerp, B-2000, Belgium|CHU Saint-Pierre, Brussels, 100, Belgium|Universitaire Ziekenhuis Gent, Gent, 9000, Belgium|Hopital de la Croix Rousse, Lyon, 69004, France|Service des Maladies Infectieuses et Tropicales du CHU de NANTES, Nantes, 44093, France|Hopital Saint Louis, Paris, 75010, France|Pitié-Salpêtrière Hospital, Paris, 75013, France|Hospital Bichat Claude-Bernard, Paris, 75018, France|Universit?tsklinikum Bonn, Bonn, 53127, Germany|Universit?tsklinikum Essen, Essen, 45147, Germany|Klinikum der Goethe-Universit?t Frankfurt, Frankfurt, 60590, Germany|ICH Infektiologisches Centrum Hamburg, Hamburg, 20146, Germany|Medizinische Hochschule Hannover, Hannover, 30625, Germany|Santa Maria Annunziata di Firenze, Firenze, 50011, Italy|San Paolo Hospital, Milan, 20142, Italy|Azienda Ospedaliera - Polo Universitario 'Luigi Sacco', Milan, 20157, Italy|Universitaria di Modena, Modena, 41124, Italy|Universitario Alicante, Alicante, 03010, Spain|Hospital General Universitario de Elche, Alicante, 03203, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, 08025, Spain|Hospital Clinic Barcelona, Barcelona, 08036, Spain|Universitari de Bellvitge, Barcelona, 08907, Spain|IrsiCaixa, Barcelona, 08916, Spain|Hospital Ramon y Cajal, Madrid, 28034, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Elton John Centre, Brighton, BN2 1ES, United Kingdom|Southmead Hospital, Bristol, BS10 5NB, United Kingdom|Bart's Hospital, London, E1 1BB, United Kingdom|Royal Free Hospital, London, NW3 2QG, United Kingdom|St Thomas Hospital, London, SE1 7EH, United Kingdom|Chelsea & Westminster Hospital, London, Sw10 9NH, United Kingdom|St Mary's Hospital, London, W2 1NY, United Kingdom|Mortimer Market Centre, London, WC1E 6JB, United Kingdom Less <<
NCT02509195 HIV Phase 4 Completed - United Kingdom ... More >> St Stephen's Centre, Chelsea & Westminster Hospital London, United Kingdom, SW10 9NH Less <<
NCT02500446 HIV Phase 4 Completed - Australia, Victoria ... More >> Melbourne Sexual Health Centre Carlton, Victoria, Australia, 3053 Alfred Hospital Prahran, Victoria, Australia, 3010 Less <<
NCT02491242 - Completed - Spain ... More >> Ramon y Cajal Hospital Madrid, Spain, 28034 Less <<
NCT02924389 HIV Not Applicable Recruiting June 2020 United States, Georgia ... More >> Grady Health System Recruiting Atlanta, Georgia, United States, 30303 Contact: Cecile Lahiri, MD    404-616-6306    cdelill@emory.edu    Ponce De Leon Center Recruiting Atlanta, Georgia, United States, 30308 Contact: Cecile Lahiri, MD    404-616-6306    cdelill@emory.edu    Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Cecile Lahiri, MD    404-616-6306    cdelill@emory.edu Less <<
NCT02401828 Human Immunodeficiency Virus PHASE4 COMPLETED 2025-07-17 Erasmus Medical Center, Rotter... More >>dam, Zuid Holland, 3000 CA, Netherlands Less <<
NCT03016533 HIV Infections Phase 3 Recruiting December 29, 2023 South Africa ... More >> GSK Investigational Site Recruiting Hillbrow, Gauteng, South Africa, 2001 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Thailand GSK Investigational Site Recruiting Chiang Mai, Thailand, 50200 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT02487706 HIV PHASE4 COMPLETED 2025-07-15 Germans Trias i Pujol Hospital... More >>, Badalona, Barcelona, 08916, Spain Less <<
NCT02566707 HIV-1 Infection Phase 2 Terminated(due to introduction... More >> of another integrase inhibitor, recruitement was not feasible anymore.) Less << - Germany ... More >> University of Bonn Bonn, Germany Netherlands Rijstate Arnhem, Netherlands Radboud University Nijmegen Medical Centre Nijmegen, Netherlands St. Elisabeth Tilburg, Netherlands Less <<
NCT05590325 Hiv PHASE1|PHASE2 RECRUITING 2024-12-31 Tygerberg Hospital, Cape Town,... More >> Western Cape, 7505, South Africa Less <<
NCT04166474 Hiv|Tuberculosis PHASE4 COMPLETED 2024-02-07 Desmond Tutu Health Foundation... More >>, Cape Town, South Africa|Infectious Diseases Institute, Kampala, Uganda Less <<
NCT03813979 HIV-1-infection|Hepatic Impair... More >>ment Less << PHASE4 WITHDRAWN 2021-12-31 -
NCT04238767 HIV-1-infection COMPLETED 2021-05-20 Butha-Buthe Government Hospita... More >>l, Butha-Buthe, Lesotho|Seboche Mission Hospital, Butha-Buthe, Lesotho Less <<
NCT04771754 HIV-1-infection on Healthy Vol... More >>unteers Less << PHASE1 COMPLETED 2024-01-10 Arnold Xhikola, London, SW10 0... More >>XD, United Kingdom Less <<
NCT04229290 HIV-1-infection PHASE4 COMPLETED 2021-09-16 Kiambu Level 5 Hospital, Kiamb... More >>u, Kenya|Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu, Kenya|Kenyatta National Hospital, Nairobi, Kenya|Thika Level 5 Hospital, Thika, Kenya Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.38mL

0.48mL

0.24mL

11.92mL

2.38mL

1.19mL

23.84mL

4.77mL

2.38mL

References

 

Historical Records

Categories